FFTY:NYE-Innovator IBD® 50 ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 27.19

Change

-0.42 (-1.52)%

Market Cap

N/A

Volume

0.12M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

-0.84 (-0.69%)

USD 15.96B
VOT Vanguard Mid-Cap Growth Index ..

-1.22 (-0.49%)

USD 14.56B
IJK iShares S&P Mid-Cap 400 Growth..

-0.44 (-0.48%)

USD 9.29B
XMMO Invesco S&P MidCap Momentum ET..

-0.55 (-0.45%)

USD 2.61B
IVOG Vanguard S&P Mid-Cap 400 Growt..

-0.64 (-0.56%)

USD 1.09B
ETHO Amplify ETF Trust

+0.01 (+0.02%)

USD 0.18B
CWS AdvisorShares Focused Equity E..

-0.24 (-0.35%)

USD 0.18B
IPO Renaissance IPO ETF

+0.02 (+0.04%)

USD 0.15B
BFOR Barron's 400 ETF

-0.10 (-0.14%)

USD 0.15B
PEXL Pacer US Export Leaders ETF

-0.12 (-0.24%)

USD 0.06B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.57% 56% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.57% 56% F 66% D+
Trailing 12 Months  
Capital Gain 28.56% 61% D- 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.56% 61% D- 70% C-
Trailing 5 Years  
Capital Gain -18.35% 39% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -18.35% 39% F 37% F
Average Annual (5 Year Horizon)  
Capital Gain -1.77% 11% F 26% F
Dividend Return -1.10% 11% F 18% F
Total Return 0.67% 67% D+ 16% F
Risk Return Profile  
Volatility (Standard Deviation) 29.64% 28% F 36% F
Risk Adjusted Return -3.72% 11% F 20% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.